Antiviral activity of staphylococcin 188: A purified bacteriocin like inhibitory substance isolated from Staphylococcus aureus AB188

Research Journal of Microbiology

Volumn 2, Issue 11, 2007, Pages 796-806

  Saeed, Sadia ^a   Rasool, Sheikh Ajaz ^a   Ahmad, Samia ^a   Zaidi, Sohail Zahoor ^b   Rehmani, Shafqat ^c  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b NATIONAL INSTITUTE OF HEALTH   (Pakistan)

^c Poultry Research Institute   (Pakistan)

Author keywords

BLIS; ELD50; NCDV; Rhabdosarcoma cells; Staphylococcin; Staphylococcus aureus AB188

Indexed keywords

ANIMALIA; PICORNAVIRIDAE; POLIOVIRUS; STAPHYLOCOCCUS AUREUS;

EID: 36349037326     PISSN: 18164935     EISSN: None     Source Type: Journal    
DOI: 10.3923/jm.2007.796.806     Document Type: Article

References (34)

1. Beard, C.W., S.R. Hopkins and J. Hammond, 1975. Preparation of new castle disease virus hemagglutination-inhibition test antigen. Avian Dis., 19: 692-699.
2. Bhunia, A.K., M.C. Johnson and B. Ray, 1987. Direct detection of an antibacterial peptide of Pediococcus acidilactici in sodium dodecyl sulfate Polyacrylamide gel electrophoresis. J. Ind. Microbiol., 02: 319-322.
3. Brugh, M.J. and C.W. Beard, 1980. Collection and processing of blood samples dried on paper for microassay of Newcastle disease virus and avian influenza virus antibodies. Am. J. Vet. Res., 41: 1495-1498.
4. Cleveland, J., T.J. Montville., I.F. Nes and M.L. Chikindas, 2001. Bacteriocins: Safe, natural antimicrobials for food preservation. Inter. J. Food Microbiol., 71: 1-20.
5. Crupper, S.S. and J.J. Iandolo, 1996. Purification and partial characterization of a novel antibacterial agent (Bac1829) produced by Staphylococcus aureus KSI1829. Applied Environ. Microbiol., 62: 3171-3175.
6. Crupper, S., A.J. Gies and J.J. Iandolo, 1997. Purification and characterization of staphylococcin BacR1, a broad-spectrum bacteriocin. Applied Environ. Microbiol., 63: 4185-4190.
7. DeCourcy, K., 2004. Column chromatography information manual. Fralin Biotechnology Center. Virginia Technol., pp: 5-17.
8. Diep, D.B. and I.F. Nes, 2002. Ribosomally synthesized antibacterial peptides in Gram-positive bacteria. Curr. Drug Targets, 3: 107-122.
9. Eaton, M.D., J.A. Heller and A.R. Scala, 1973. Enhancement of lymphoma cell immunogenicity by infection with non-oncogenic virus. Cancer Res., 33: 3293-3298.
10. Eijsink, V.G.H., M. Skeie, P.H. Middelhoven, M.B. Brurberg and I.F. Nes, 1998. Comparative studies of class IIa bacteriocins of lactic acid bacteria. Applied Environ. Microbiol., 64: 3275-3281.
11. Ennahar, S., N. Deschamps and J. Richard, 2000. Natural variation in susceptibility of Listeria strains to class IIa bacteriocins. Curr. Microbiol., 41: 1-4.
12. Furmanek, B., T. Kaczorowski., R. Bugalski., K. Bielawski., J. Bogdanowicz and A.J. Podhajska, 1999. Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant. J. Applied Microbiol., 87: 856-866.
13. Grist, E.J., E.A.C. Follet., E.J. Bell and G.E.D. Urquhart, 1979. Diagnostic Methods in Clinical Virology. 3rd edition. Blackwell Scientific Publications, Oxford, pp: 44-140.
14. Iqbal, A., S.A. Ali, A. Abbasi, W. Volter and S.A. Rasool, 2001. Production and some properties of Bac201: A bacteriocin like inhibitory substance from Staphylococcus aureus AB201. J. Basic Microbiol., 41: 25-36.
15. Jack, R.W., J.R. Tagg and B. Ray, 1995. Bacteriocins of Gram-positive bacteria. Microbiol. Rev., 59: 171-200.
16. Jassim, S.A.A. and M.A. Naji, 2003. Novel antiviral agents: A medicinal plant perspective. J. Applied Microbiol., 95: 412-430.
17. Kott, V., L. Barbini, M. Cruane, J.D. Munoz, E. Vivot, J. Cruanes, V. Martino and G. Ferraro, 1999. Antiviral activity in Argentine medicinal plants. J. Ethnopharmacol., 64: 79-84.
18. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227: 680-685.
19. Lin, S.B., C.H. Lin and Y.L. Hsu, 2001. Establishment of an antiviral activity assay and the partial purification of interferon-like protein from rainbow trout gonadal cells (RTG-2). Zoo. Stu., 40: 240-248.
20. Maganusson, J. and J. Schnürer, 2001. Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Applied Environ. Microbiol., 67: 1-5.
21. Modak, B., H. Galeno and R. Torres, 2004. Antiviral activity on Hantavirus and apoptosis of vero cells of natural and semi-synthetic compounds from Heliotropium fulifolium resin. J. Chil. Chem. Soc., 49: 143-149.
22. Murinda, S.E., K.A. Rashid and R.F. Robert, 2003. In vitro assessment of the cytotoxicity of nisin, pediocin and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J. Food Prot., 66: 847-853.
23. Nakamura, T., N. Yamazak, H. Taniguchi and S. Fujimura, 1983. Production, purification and properties of a bacteriocin from Staphylococcus aureus isolated from saliva. Infect. Immun., 39: 609-614.
24. Nascimento, D.S.J., P.C. Fagundes, D.P. Brito and K.R. Santos, 2005. Production of bacteriocins by coagulase-negative staphylococci involved in bovine mastitis. Vet. Microbiol., 106: 61-71.
25. Oakey, L., K. Caroll, S. McClean, F. Kelleher, M. Costello and J. Behan, 2003. Antimicrobial peptides - alternative to antibiotics? Irish Sci., 2: 85-95.
26. Ogunbanwo, S.T., A.I. Sanni and A.A. Onilude, 2003. Characterization of bacteriocin produced by Lactobacillus plantarum F1 and Lactobacillus brevis OG1. Afr. J. Biotechnol., 2: 219-227.
27. Perbal, B., 1988. Basic Methods in Molecular Biology. In: A practical Guide Line to Molecular Cloning. 2nd Edn., John and Wiley and Sons Inc. pp: 11-35.
28. Rubinstein, S., P.C. Familletti and S. Pestka, 1981. Convenient assay for interferon J. Virol., 37: 755-758.
29. Schirrmacher, V., C. Haas and R. Bonifer, 1997. Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection. Clin. Cancer Res., 3: 1135-1148.
30. Schirrmacher, V., T. Ahlert and T. Pröbstle, 1998. Immunization with virus-modified tumor cells. Semin. Oncol., 25: 677-696.
31. Seal, B.S., D.J. King and H.S. Sellers, 2000. The avian response to New Castle Disease Virus. Dev. Comp. Immunol., 24: 257-268.
32. Waschmann, M.B., M.E. Farias, E. Takeda, F. Sesma, A.P. R. Holgado, A. Torres and C.E. Coto, 1999. Antiviral activity of enterocin CRL 35 against herpesviruses. Int. J. Antimicrob. Agents, (12): 293-299.
33. Waschmann, M.B., M.E. Farias, E. Taked, F. Sesma, A.P.R. Holgado, A. Torre and C.E. Coto, 2003. Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Int. J. Aritimicrob. Agents, 12: 293-299.
34. Whitford, W.F., M.A. McPherson, R.J. Foster and R.M. Teather, 2001. Identification of bacteriocin-like inhibitors from rumen Streptococcus spp. and isolation and characterization of Bovicin 255. Applied Environ. Microbiol., 67: 569-574.